Ann: TGA Registration Update, page-431

just to expand my post yesterday and what I'm expecting in the 4c tomorrow. refreshes my memory and may help some newer investors !!!

- the last distribution agreement was oct 18th, over 3 months ago. we were announcing a partner every 1-2 weeks at that stage ,when the ASX stopped us releasing them as ASX ann's . IMO it would be highly unlikely that we haven't signed more distributors in that time.

-  individual country registration and sales, from the AGM, Italy and Spain granted, Greece and Turkey very close, clinical trial started in Malaysia and Phillipines, UK in stage 3 of DHSC approval (finished early 2022)

we are for sale on Ramma Dental's website, so Greece/Cyprus must be granted post 58862555 as well as in Italy with Exxe post 58858214

we have examples of being told that we are selling into Europe in nearly all recent media such as
"Several Australian companies have developed COVID RATs locally, although at least two are waiting on TGA approval for tests that are already in use in Europe or North America. Brisbane-based AnteoTech is one of those."

an update on the UK trial.  the initial successful UK trial phase 1/2 of the DHSC approval was completed and Derek told us that we are in the final stage3 of approval which requires  5000 samples tested, which was to be completed  in the NY.

-how close are our sepsis tests and multiplex covid/flu test from starting trial validation? how is our move into the US progressing partnering with the marketing team Ellume used?

-update on commercialisation of battery collaborations. I'll borrow from semi's post today
"a simple additive gives 26% increase in energy retention from just a drop in solution is worth $billions to battery manufacturers to extend the range of E vehicle transport , The energy division also has a x-link binder and a high up to 70% silicone / graphite composite material that will be very disruptive to the battery world"

-brisbane manufacturing update, getting the machines operational will give us more volume to be available if demand is there. 12m strips per year or multiples if extra shifts are used.

-revenue, hopefully we will see an increase, will depend on payment structures since the new ellume deal was signed nov 24th and the Marylands facility has only just started producing. also with any European sales both Exxe and Ramma dentals website additions were only spotted by our forum in mid January.

if the last few 4c's are a guide, we should be getting a substantial update on the companies progress. TGA approval is very important for us but so are all the above aspects of the company.

Monday will be another interesting day...... GLTAH, DYOR, IMO etc

2022 the year of ADO, life science + batteries